Status:
RECRUITING
Dermatitis During Adjuvant Irradiation for BREAst Cancer:
Lead Sponsor:
University Hospital Schleswig-Holstein
Collaborating Sponsors:
University of Southern Denmark
Medical School Hamburg
Conditions:
Breast Cancer Female
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
In the randomized DAI-BREAC trial, a reminder app will be prospectively tested that reminds breast cancer patients four times each day to perform the required skin care. This will likely contribute to...
Detailed Description
The main goal of this trial is to evaluate whether standard skin care supported by a reminder app is superior to standard skin care alone with respect to prevention of grade ≥2 radiation dermatitis in...
Eligibility Criteria
Inclusion
- Histologically proven invasive breast cancer
- Indication for adjuvant hypo-fractionated radiotherapy
- Possession of and ability to use a smartphone
- Female gender
- Age ≥18 years
- Written informed consent
- Capacity of the patient to contract
Exclusion
- Pregnancy, Lactation
- Expected non-compliance
Key Trial Info
Start Date :
December 23 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2026
Estimated Enrollment :
268 Patients enrolled
Trial Details
Trial ID
NCT06483477
Start Date
December 23 2024
End Date
September 30 2026
Last Update
January 16 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Vejle Hospital, University Hospital of Southern Denmark
Vejle, Southern Denmark, Denmark, 7100
2
Medical Practice for Radiotherapy and Radiation Oncology
Hanover, Lower Saxony, Germany, 30161
3
Medical School Hamburg, Schwerin Campus
Schwerin, Mecklenburg-Vorpommern, Germany, 19055
4
Malteser Hospital St. Franziskus
Flensburg, Schleswig-Holstein, Germany, 24939